0001209191-19-011362.txt : 20190219 0001209191-19-011362.hdr.sgml : 20190219 20190219193858 ACCESSION NUMBER: 0001209191-19-011362 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190214 FILED AS OF DATE: 20190219 DATE AS OF CHANGE: 20190219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Popovits Kimberly J CENTRAL INDEX KEY: 0001333482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 19616789 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-14 0 0001131324 GENOMIC HEALTH INC GHDX 0001333482 Popovits Kimberly J 301 PENOBSCOT DR. REDWOOD CITY CA 94063 1 1 0 0 President and CEO Common Stock 2019-02-14 4 M 0 47900 17.18 A 164882 I Held by the Popovits 2010 Trust Common Stock 2019-02-14 4 S 0 34000 81.4608 D 130882 I Held by the Popovits 2010 Trust Common Stock 2019-02-14 4 S 0 13900 82.2984 D 116982 I Held by the Popovits 2010 Trust Common Stock 68028 D Common Stock 12298 I Held by Morgan Stanley as Custodian for Benefit of Kimberly Popovits Employee Stock Option (right to buy) 17.18 2019-02-14 4 M 0 47900 0.00 D 2020-02-18 Common Stock 47900 0 D These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on May 17, 2018. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents weighted average sale price. Actual sale prices ranged from $81.05 to $82.045. Represents weighted average sale price. Actual sale prices ranged from $82.06 to $82.83. Includes an aggregate of 62,164 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. The option became exercisable as to 25% of the shares on February 18, 2011, and became exercisable as to 1/48th of the shares each full month thereafter. /s/ Jason W. Radford, Attorney-in-fact 2019-02-19